Skip to Main Content
Q+A

‘A Strong Future for Pediatric Medicine’—A Q&A with Tara Henderson

7 Minute Read

Tara Henderson, MD, MPH, took the helm of Yale School of Medicine’s Department of Pediatrics on Oct. 1. A pediatric oncologist, she has spent her career caring for children with cancer and studying the effects those early-life experiences have on her patients’ future health.

As chair, she aims to inspire the next generation of pediatricians, build connections, and harness the multidisciplinary, collaborative expertise at Yale to strengthen pediatric care now and into the future.

We spoke with Henderson about her practice, research, goals, and her excitement about returning to the East Coast. This interview has been edited and condensed for clarity.

How would you describe your research interests?

Tara Henderson, MD, MPH: I'm a pediatric oncologist and a health services researcher, and my clinical care and research focuses on the long-term health of people who were diagnosed with cancer as children, adolescents, or young adults.

We've gotten increasingly successful at treating childhood, adolescent, and young adult (AYA) cancer. And with that, we've started to see childhood and AYA cancer survivors age into adulthood. One of the great successes in oncology is that we are curing more children and young people with cancer. As a result, we now have a growing population of survivors living well into adulthood. That has given us the opportunity—and the responsibility—to understand how cancer and its treatments affect health across the lifespan.

My particular focus is subsequent cancers in survivors. I study why some survivors develop new cancers later in life, how their risk compares with that of the general population, and how we can identify those at highest risk. Ultimately, the goal is to translate that knowledge into better screening and prevention so survivors can live long, healthy lives.

This work also teaches us something more fundamental about cancer. By comparing survivors who develop subsequent cancers with those who don’t, we can understand how treatment exposures, genetics, and behavioral and lifestyle factors interact to influence cancer risk. That, in turn, helps us become more precise about whom we screen, how we screen them, and where prevention efforts can have the greatest impact.

How do the research side and the clinical side of your work intersect?

Henderson: I have taken care of long-term cancer survivors, from two years off therapy through the rest of their life, throughout my entire career. I sometimes describe my patients as a living laboratory. I don’t have a traditional laboratory with pipettes and test tubes. Instead, I listen to my patients, observe the health issues that emerge over time, and ask questions based on what I am seeing in the clinic. Those observations often become research questions, and the research comes back to inform how we care for patients.

Because childhood cancer is relatively rare, this work also depends enormously on collaboration. I’ve had the privilege of working with large cohorts and consortia across the United States, North America, and internationally. Bringing those patients and investigators together allows us to answer questions we could never answer at a single institution.

What made you say yes to Yale School of Medicine?

Henderson: I got excited about a couple of things. First, the people and the culture. I really was impressed with the curiosity and wonderful way the people that I met interacted with me. There was a genuine, bidirectional curiosity about ideas for clinical healthcare and health systems, science, and medical education. I was drawn to the culture that clearly values both outstanding clinical care and outstanding science—and understands that the two should continually inform one another.

And there is an extraordinary opportunity of being at Yale. It is one of the great academic institutions in the world, with remarkable leadership and expertise across medicine, public health, policy, basic science, and beyond. I’m excited to think creatively about how we care for children throughout Connecticut and beyond, how we grow the pediatric health system, and how we bring the breadth of Yale to bear on the health of children.

I'm quite excited to get started.

What are your goals as chair, thinking about the first days and months and then more long term?

Henderson: My first priority is to listen. When you come into a new institution, you need to understand the people, the culture, what is working well, where the opportunities are, and what people aspire to build. Taking the time to develop relationships and trust at the beginning will allow us to move much faster together later.

Longer term, one of the issues I care deeply about is the future pediatric workforce. Across the country, pediatrics is facing real workforce challenges. We need to inspire medical students to choose pediatrics and then help our residents see the tremendous opportunities within pediatric subspecialties. If we want a strong future for pediatric medicine, we have to excite the next generation about taking care of children.

I also bring a lifespan perspective from oncology. What happens to you as a child can shape your health for the rest of your life. That is obviously true for childhood cancer survivors, but it is also true across many pediatric diseases and conditions.

Yale is an extraordinary place to think about those questions because we can bring together people not only from across medicine, but also from public health, social science, economics, law, engineering, and other disciplines. Some of the most interesting problems in child health are not going to be solved by pediatrics alone.

I'm also really excited to get to work with Eric Winer, MD, Yale Cancer Center, and Smilow Cancer Hospital. There are already outstanding people thinking about adolescent and young adult oncology and survivorship. I see real opportunities to build on that work and create even stronger partnerships across the health system.

What do you want people to know about you?

Henderson: I am from the East Coast. I grew up in New Jersey, lived there until I was 22 years old. I like to say I’m a seventh-generation Jersey girl, so coming back east feels a little like coming home.

I have a husband who's also an academic and three kids. I am a people person. I love to talk and get to know people. I love meeting people, hearing what they are working on, and figuring out how to connect them with someone who might help them think differently or open a new door. That is particularly important to me with students, trainees, and junior faculty. Over the years, I’ve learned how powerful it can be to bring people together across disciplines and across very different experiences.

One of the formative experiences in my career was an American Society of Clinical Oncology leadership program. My cohort included people from pediatric oncology, community oncology, breast oncology, geriatric oncology, and international oncology. I loved learning how people who approached healthcare from very different perspectives thought about problems. That experience led me to Presidential Leadership Scholars, which brought together leaders from many different sectors across the country. Again, what struck me was how much better you can understand a problem when you put people around the table who see it differently.

That is something I hope to bring to Yale. When we approach difficult questions from multiple perspectives and connect people who might not otherwise find one another, we can come up with much more creative solutions.

I read that you love painting and drawing, and that you once thought you'd be an architect. Do you still paint and draw?

Henderson: Not nearly enough! Right now, I’m living a little vicariously through my daughter, who is a senior in college and a very talented visual artist. We were recently looking at a house that had once been owned by an artist and a well-known architect. There was a small room that had been the artist’s studio, and I immediately told my daughter, “That’s going to be my office—and I’m putting an easel in there.”

I would love to start painting and drawing again. There is something about making art that clears your mind and forces you to look at things differently. In some ways, though, I think I still use that part of my brain all the time in science. Good science requires creativity. You have to frame a problem differently, figure out the right question to ask, and often bring together the right combination of people to answer it. That’s probably where most of my creative energy has gone in recent years.

Article outro

Author

Mallory Locklear, PhD
Managing Editor—Science, Research, and Education

Tags

Media Contact

For media inquiries, please contact us.

Explore More

Featured in this article